Ria Health Raises Series B to Expand AUD Treatment
Deal News | Mar 06, 2025 | SV Health Investors, LLC
Ria Health, a telehealth provider specializing in alcohol use disorder (AUD) treatment, has secured growth capital through a Series B equity round led by Peloton Equity. Other participating investors include SV Health Investors, BPEA Private Equity, and SOSV. The capital will be utilized to scale Ria Health's clinical model and payor coverage, and to amplify investments in sales and marketing as well as the company’s unique position in AUD care. Ria Health employs a clinical model that integrates medication-assisted treatment, behavioral therapy, and coaching, focusing on patient outcomes and clinical efficacy. The funding round sees Michael O'Rourke from Peloton Equity joining Ria Health's Board of Directors, which includes prominent figures from the healthcare industry. This investment marks a significant milestone for Ria Health, advancing its goal to revolutionize AUD treatment through evidence-based and patient-focused care.
Sectors
- Healthcare
- Telehealth
- Private Equity
Geography
- United States – Ria Health operates across all 50 states, and the article highlights the U.S. focus in AUD telehealth services.
- United Kingdom – SV Health Investors have offices in London, contributing a UK aspect to this article.
Industry
- Healthcare – The article centers on Ria Health’s growth within the healthcare sector, specifically focusing on alcohol use disorder treatment.
- Telehealth – Ria Health provides its AUD treatment services through telehealth platforms, making it a key player in the telehealth sector.
- Private Equity – The involvement of private equity firms such as Peloton Equity and SV Health Investors in financing Ria Health illustrates the activity within the private equity industry.
Financials
- Series B Funding – Ria Health has secured a Series B funding round, though the specific financial amount is not disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Ria Health | Target Company | Company | A healthcare company providing telehealth-based treatment for alcohol use disorder. |
| Peloton Equity, LLC | Lead Investor | Company | A private equity firm investing growth capital in healthcare. |
| SV Health Investors | Investor | Company | A private equity firm investing in healthcare and life sciences. |
| BPEA Private Equity | Investor | Company | A private equity firm focusing on small and lower middle market investments. |
| SOSV | Investor | Company | A global venture capital firm providing multi-stage investment. |
| Bill Stapleton | CEO | People | CEO of Ria Health, leading the company in its growth strategies. |
| Michael O'Rourke | Board Member | People | Partner at Peloton Equity and new Board member at Ria Health. |
| Carol Vallone | Board Member | People | Chair of the Board of Trustees at McLean Hospital and serving on Ria Health's Board. |
| Dr. Martin Rosenzweig | Board Member | People | Former Chief Medical Officer at UnitedHealthGroup and a member of Ria Health's Board. |
| Michael Balmuth | Managing Partner | People | Managing Partner at SV and a member of Ria Health's Board. |
| Dr. John Mendelson | Founder and Chief Medical Officer | People | Founder and Chief Medical Officer of Ria Health. |